Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients

Ibarra‐Lecue, I., Unzueta‐Larrinaga, P., Barrena‐Barbadillo, R., Villate, A., Horrillo, I., Mendivil, B., Landabaso, M. A., Meana, J. J., Etxebarria, N., Callado, L. F., & Urigüen, L. (2022). Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients. Addiction Biology, 27(6). Portico. https://doi.org/10.1111/adb.13233
Authors:
Inés Ibarra-Lecue
Paula Unzueta-Larrinaga
Rocío Barrena-Barbadillo
Aitor Villate
Igor Horrillo
Begoña Mendivil
Miguel A Landabaso
J Javier Meana
Nestor Etxebarria
Luis F Callado
Leyre Urigüen
Affiliated Authors:
Inés Ibarra-Lecue
Subjects:
Schizophrenia (MeSH)
Cannabis (MeSH)
Author Keywords:
5-ht2ar
akt
biomarkers
cannabis use disorder
dual diagnosis
endocannabinoids
il-6
schizophrenia
Publication Type:
Article
Unique ID:
10.1111/adb.13233
PMID:
Publication Date:
Data Source:
PubMed

Record Created: